Sarsia is an early stage venture capital investor based in Bergen, Norway. We invest in science based technology companies within energy/cleantech and biotechnology/life science. Our strength lays in our technological competence, experience and extensive national and international network of industry and co-investors. Sarsia Seed Fund I has been operational since 2007 and contains 22 investments, 5 Exits, three IPO and 14 portfolio companies. More than 2bEUR has been created in shareholdervalue in the portfolio since Sarsia entered as first institutional investor. Sarsia Seed Fund II has been operational since Summer 2017 and have 14 portfolio companies.